Colonel William A. Phillips

Edit links

James W. Carroll Jr. is an American attorney and government appointee, who served as director of the Office of National Drug Control Policy in the Trump Administration from February 9, 2018 until January 20, 2021.[1][2]

Education

Carroll received his B.A. from the University of Virginia and his J.D. degree from George Mason University.[3]

Career

General Counsel in the Office of Management and Budget, and an attorney in the Office of the White House Counsel for Presidents Donald Trump and George W. Bush.[4] He later served as the White House Deputy Chief of Staff.[5]

Photo of Carroll

He was confirmed by the U.S. Senate as Office of National Drug Control Policy on January 2, 2019. Carroll was sworn into office by Vice President Mike Pence on January 31.[6]

In 2021, Carroll compared fentanyl to weapons of mass destruction.[7]

References

  1. ^ "President Donald J. Trump Announces Appointments for the Executive Office of the President". whitehouse.gov. Retrieved February 9, 2018 – via National Archives.
  2. ^ "PN1864 — James W. Carroll Jr. — Executive Office of the President". U.S. Congress. Retrieved April 26, 2018.
  3. ^ "Jim Carroll – The White House". trumpwhitehouse.archives.gov. Retrieved 2023-07-08.
  4. ^ "President Donald J. Trump Announces Key Additions to the Office of the White House Counsel". whitehouse.gov. Retrieved March 7, 2017 – via National Archives.
  5. ^ Restuccia, Andrew; Karni, Annie (December 21, 2017). "Trump eyes former aides as West Wing staffers depart". Politico.
  6. ^ "APhA Attends Swearing-In Ceremony of National Drug Control Policy Director". American Pharmacists Association. February 4, 2019. Archived from the original on September 8, 2020. Retrieved March 16, 2019.
  7. ^ Vazquez, Maegan (2021-09-30). "Biden administration grapples with American addiction as overdose deaths hit a record high | CNN Politics". CNN. Retrieved 2023-07-08.

External links

Political offices
Preceded by
Rich Baum
Acting
Director of the Office of National Drug Control Policy
2018–2021
Acting: 2018–2019
Succeeded by
Regina LaBelle
Acting